Skip to main content

Annals of Hematology

Ausgabe 8/2005

Inhalt (13 Artikel)

Review Article

Chronic myeloid leukemia: a model for oncology

Rüdiger Hehlmann, Ute Berger, Andreas Hochhaus

Original Article

Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin’s lymphoma

Lars Møller Pedersen, Tobias Wirenfeldt Klausen, Ulla Høy Davidsen, Hans Erik Johnsen

Original Article

Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma

Jan-Peter Glossmann, Jan Oliver Staak, Lucia Nogova, Volker Diehl, Christoph Scheid, Jens Kisro, Hans-Edgar Reis, Norma Peter, Andreas Engert, Andreas Josting

Original Article

Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response

Siddhartha Ganguly, Clint L. Divine, Delva Deauna-Limayo, David C. Bodensteiner, James D. Cook, Jan N. Lewis, Barry S. Skikne

Original Article

Analysis of leukocyte binding to depletion filters: role of passive binding, interaction with platelets, and plasma components

R. Henschler, B. Rüster, A. Steimle, H. L. Hansmann, W. Walker, T. Montag, E. Seifried

Letter to the Editor

Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab

S. Vallet, A. Tempescul, A. Tran, M. C. Legrand-Quillien, V. Narbonne, C. Berthou

Letter to the Editor

Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma

Kazutaka Takagi, Akira Yoshida, Hiromichi Iwasaki, Hitoshi Inoue, Takanori Ueda

Letter to the Editor

Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab

Soon Thye Lim, Nancy Rubin, Jonathan Said, Alexandra M. Levine

Letter to the Editor

An unusual presenting feature of precursor T-cell acute lymphoblastic leukemia/lymphoma

Me-Ae Kim, Gyeong-Won Lee, Kook-Young Maeng

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.